A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer. - Liu X; Moamer A; Gomes da Silva R; Shoham-Amizlev A; Hamam D; Shams A; Lebrun JJ; Ali S (Cell death & disease, 2025)